Citadel Advisors »

Bioline Rx shares owned by Citadel Advisors

Quarter-by-quarter ownership of Bioline Rx (BLRX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Bioline Rx

Tip: Access up to 7 years of quarterly data

All positions including Bioline Rx held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioline Rx by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $38k 10k 3.78
2025-06-30 $323k 71k 4.57

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Bioline Rx

Susquehanna International
Citadel Advisors
UBS Group
Rhumbline Advisers
Wells Fargo & Company
Nemes Rush Group
Goss Wealth Management
Simplex Trading
Tower Research Capital
Rockefeller Capital Management
SBI Securities
Danske Bank A/s
Advisor Group Holdings

View all funds holding Bioline Rx